Alpine Immune Sciences

Alpine Immune Sciences

  • Founded: 2015
  • Location: Seattle, WA
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: Systemic lupus erythematosus (partner: AbbVie)
  • Drug types: IMM, NPH, HEM
  • Lead product: Acazicolcept
  • Product link:
  • Funding: $100M stock Sep 2022; $91M stock Sep 2021; $48M Jun 2016

job board

Short description:


Drug notes:

Povetacicept Clin1b SLE, Clin1b glomerulonephritis, Clin1a cytopenia; 2 undisclosed programs Clin0 undisclosed

Long description:

Alpine Immune Sciences is taking a unique approach to immunology to treat cancer, autoimmune and inflammatory diseases. Alpine is using protein engineering strategies, such as their proprietary directed evolution platform, to turn immune proteins into multi-targeted therapeutics that can modulate the human immune system. The platform is highly flexible and has been used by Alpine to enhance the activity of native IgSF and TNFSF, which can then be used for many therapeutic formats like Fc fusion, cell therapy or monoclonal antibodies. Therefore, a single directed evolution campaign can have several final formats. Alpine’s diverse pipeline consists of both wholly-owned programs and partnered programs in development for immuno-oncology and inflammatory diseases such as Lupus.


Alpine Immune Sciences
Sr. Associate Scientist/Scientist - Research Pharm...
Seattle, WA-OnsiteOn-site|27 days ago
Alpine Immune Sciences
Process Engineer (Upstream)
Seattle, WA-HybridHybrid|100+ days ago
Alpine Immune Sciences
Process Engineer (Downstream)
Seattle, WA-HybridHybrid|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy